$NTRA 3 SEC Filings

Filed On	Filing
09 Jun 2026	Form 3: Lynch Thomas J. Jr., Director No securities owned
09 Apr 2026	Form 3: Rubin Eric H, Director No securities owned
14 Mar 2025	Form 3: Bertagnolli Monica, Director No securities owned
30 Jan 2024	Form 3: Moshkevich Solomon, President, ClinicalDiagnostics Holds 167,051 shares of Common Stock
30 Jan 2024	Form 3: Fesko John, PRESIDENT, CHIEF BUS. OFFICER Holds 79,500 shares of Common Stock
10 Mar 2023	Form 3: Williams Brinkley Ruth, Director No securities owned
23 Apr 2021	Form 3: Rabinowitz Daniel, CHIEF LEGAL OFFICER Holds 44,257 shares of Common Stock
25 Nov 2020	Form 3: Bertagnolli Monica, Director No securities owned
23 Aug 2019	Form 3: Chapman Rowan E, Director No securities owned
15 Jan 2019	Form 3: Schueren Robert Alan, Chief Operating Officer No securities owned
02 Aug 2018	Form 3: Baynes Roy D., Director No securities owned
18 Jul 2017	Form 3: Chapman Steven Leonard, Chief Operating Officer
28 Mar 2017	Form 3: Marcus Gail Boxer, Director No securities owned
13 Feb 2017	Form 3: Brophy Michael Burkes, Chief Financial Officer
01 Jul 2015	Form 3: Lightspeed Venture Partners Viii Lp, 10% owner and 6 others
01 Jul 2015	Form 3: Healy James, Director
01 Jul 2015	Form 3: Steuart John, Director Holds 0 shares of No securities are beneficially owned
01 Jul 2015	Form 3: Claremont Creek Ventures L P, 10% owner and 2 others
01 Jul 2015	Form 3: Driscoll Edward C. Jr., Director Holds 0 shares of No securities are beneficially owned
01 Jul 2015	Form 3: Sc Xii Management Llc, 10% owner and 3 others Holds 340,660 shares of Common Stock

Comments